recombinant human lactoferrin (Meristem)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant human lactoferrin (Meristem)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLactotransferrin stimulants
TargetsLactotransferrin
Therapy Area/IndicationsLacrimal Apparatus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeristem Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeristem Therapeutics
Active IndicationsN/A
Inactive IndicationsLacrimal Apparatus Diseases

Other Information

ATC CodeN/A
Related LinksN/A